Human Genome Sciences Inc (NASDAQ:HGSI) to Release Q3 2008 Earnings November 6

Human Genome Sciences, Inc (NASDAQ:HGSI) will release the third quarter earnings for 2008 on Thursday, November 6 following the market close.  A conference call will be held that afternoon at 5:00 pm ET to discuss the financial results.  Investors are invited to hear the call by dialing 866-550-6338 or 347-284-6930.  The passcode for the call is 6760480.

Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: Albuferon for chronic hepatitis C, LymphoStat-B for systemic lupus erythematosus and ABthraxtm for inhalation anthrax. All three of these products are progressing toward commercialization. HGS also has a portfolio of drugs in earlier stages of development, led by its TRAIL receptor antibodies in mid-stage development for cancer, and substantial financial rights to three drugs in the GlaxoSmithKline (GSK) clinical pipeline.

Read more Business News on The Global Market Directory.

About The Global Market Directory (TheGMD)

TheGMD is a financial networking community for Public Companies, Brokerage Firms, Stock Brokers and Individuals. Members can network and link with each other, participate in discussions on financial stock message boards, display pictures and upload videos.

The GMD is a member of the TransWorldNews, Inc. family of sites. Members can distribute press releases through The GMD and receive distribution over all TransWorldNews news outlets.

Create your profile on The Global Market Directory